Review
doi: 10.1038/nri774.
Spinning molecular immunology into successful immunotherapy
Affiliations
- PMID: 12001994
- DOI: 10.1038/nri774
Item in Clipboard
Review
Spinning molecular immunology into successful immunotherapy
Nat Rev Immunol.
2002 Apr.
Abstract
Until recently, immunotherapies have been of limited success, particularly against cancer. However, recent insights into the cells, molecules and signalling pathways that regulate immune responsiveness are providing new approaches for immunotherapy. In this article, I review some of the most promising molecular and cellular targets for immunotherapy and discuss approaches that use these targets to amplify immune responses and potentially break antigen-specific tolerance. These strategies provide a blueprint for the development of successful immunotherapy over the next decade.
Similar articles
-
Poxviruses as vectors for cancer immunotherapy.Curr Opin Drug Discov Devel. 2003 Mar;6(2):161-8. Curr Opin Drug Discov Devel. 2003. PMID: 12669450 Review.
-
[Immunotherapy for cancer--modern immunologic strategies in oncology].Dtsch Med Wochenschr. 2008 Oct;133(41):2105-8. doi: 10.1055/s-0028-1091251. Epub 2008 Oct 1. Dtsch Med Wochenschr. 2008. PMID: 18985564 Review. German.
-
Imaging the immune response to monitor tumor immunotherapy.Expert Rev Vaccines. 2009 Oct;8(10):1427-37. doi: 10.1586/erv.09.100. Expert Rev Vaccines. 2009. PMID: 19803763 Review.
-
Viral vectors for gene transfer into antigen presenting cells.Curr Opin Mol Ther. 1999 Oct;1(5):558-64. Curr Opin Mol Ther. 1999. PMID: 11249662 Review.
-
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.J Gene Med. 2004 Nov;6(11):1175-88. doi: 10.1002/jgm.615. J Gene Med. 2004. PMID: 15468193 Review.
Cited by
-
MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.Cancer Immunol Immunother. 2004 Jun;53(6):525-32. doi: 10.1007/s00262-003-0486-4. Epub 2004 Jan 17. Cancer Immunol Immunother. 2004. PMID: 14730400 Free PMC article.
-
B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.PLoS One. 2010 May 24;5(5):e10800. doi: 10.1371/journal.pone.0010800. PLoS One. 2010. PMID: 20520738 Free PMC article.
-
A nanoelectronic enzyme-linked immunosorbent assay for detection of proteins in physiological solutions.Small. 2010 Jan;6(2):232-8. doi: 10.1002/smll.200901551. Small. 2010. PMID: 19882688 Free PMC article.
-
Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine.PLoS One. 2015 Sep 21;10(9):e0138686. doi: 10.1371/journal.pone.0138686. eCollection 2015. PLoS One. 2015. PMID: 26390407 Free PMC article.
-
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.J Transl Med. 2005 Mar 2;3(1):10. doi: 10.1186/1479-5876-3-10. J Transl Med. 2005. PMID: 15740633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
